Zoetis doubles down on AI-enabled animal diagnostics with VitalRADS acquisition
Published by AINave Editorial • Reviewed by Ramit
Zoetis, the animal health company, has agreed to acquire VitalRADS, a Texas-based network of specialists that review animal radiology images around the clock. The deal gives Zoetis access to a database of more than 30 million animal radiology images, which it plans to use as training data for AI models that can eventually automate much of the technicians' workflow, Abhay Nayak, head of US commercial operations, told Semafor.
What happened
Zoetis is acquiring VitalRADS to accelerate its push into AI-powered animal diagnostics. The company will use VitalRADS' database of over 30 million animal radiology images to train AI models. This is Zoetis' second data-focused acquisition this year, following its $160 million purchase of Neogen's animal genomics business, which gave it a large database of genetic testing records from customers across 120 countries. Zoetis executives say the deal speeds product-building by providing both data and radiologists, reducing time to deployment.
Why AI builders should care
This deal illustrates how non-tech companies are pursuing AI by acquiring data-heavy capabilities rather than building from scratch. For AI builders, the takeaway is clear: proprietary data assets are becoming the primary differentiator in vertical AI applications. Zoetis is betting that access to a large, curated dataset of animal radiology images will give it a defensible advantage over competitors building generic veterinary AI models. The strategy mirrors a broader trend in healthcare AI where companies scale data assets to accelerate model development and deployment.
Practical implications
Zoetis plans to integrate radiology workflow improvements with its existing herd-management software, expanding its AI-enabled product portfolio. The company aims to build AI models that can automate parts of veterinary technicians' workflows, potentially reducing diagnostic turnaround times and operational costs. However, creating a model for animal radiology is more complex than human radiology because of the many different species and less standardization across scans, Nayak noted.
Caveats
Zoetis has not disclosed the acquisition price for VitalRADS. The company faces market headwinds: pet owners in the US are spending less, vet visits are declining, and Zoetis' share price dropped about 30% after its most recent earnings announcement. Technical challenges also remain. Applying AI to multi-species veterinary imaging is harder than human radiology due to non-standardized data across species. The timeline for deploying AI models trained on VitalRADS data is not specified.
